Brief: Zentek Ltd Announces Promising Preclinical Safety And Toxicity Results Achieved By Triera Biosciences Ltd. For C19HBA
25/03/2024 18:29
March 25 (Reuters) - Zentek Ltd ZEN.V :
* ZENTEK LTD - ANNOUNCES PROMISING PRECLINICAL SAFETY AND
TOXICITY
RESULTS ACHIEVED BY TRIERA BIOSCIENCES LTD. FOR C19HBA
Source text for Eikon: ID:n0001062993-24-006979
Further company coverage: ZEN.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentek
See all newsNASDAQ RESUMED AT 12:30 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 11:46 AM
Brief: Zentek Announces Appointment Of Mohammed Jiwan As CEO
Brief: Zentek Withdraws Submission To Health Canada Pest Management Regulatory Agency For Zenguard Enhanced Air Filters
Brief: Zentek Ltd & Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) Using Multivalent Aptamer Technology